Tubercular Intestinal Strictures Show a Poor Response to Anti-Tuberculous Therapy
Abstract
Background
The literature on resolution of intestinal strictures in patients with intestinal tuberculosis (ITB) after anti-tuberculous therapy (ATT) is sparse and ambivalent. We aimed to assess the frequency of stricture resolution after ATT and its predictors.
Methods
This ambispective cohort study included consecutive ITB patients with strictures who received ATT for ≥6 months and were on regular follow-up between January 2004 and December 2015. Resolution of stricture was assessed at the end of ATT by endoscopy/radiology.
Results
Of 286 patients, 128 had strictures, and 106 were finally included (63 males, median age 35 years). The stricture location was distal ileum/ileocecal in 52 (49.1%), colon in 37 (34.9%), ileocolonic in 4 (3.8%), proximal small bowel in 10 (9.4%), and gastroduodenal in 4 (3.8%) patients. Although all patients demonstrated mucosal healing (indicating resolution of active infection), stricture resolution occurred only in 25/106 (23.6%) patients. Symptoms pertaining to stricture (pain abdomen/recurrent SAIO) were present in 104/106 (98%) patients, and after a median of 6 (6–9) months of ATT, these symptoms resolved only in half, 88% (22/25) in patients with stricture resolution and 38% (30/79) in patients with persistent strictures. Colonic strictures had the least resolution (5.4%) followed by proximal small intestinal (20%) and distal ileal/ileocecal (36.5%). Although not statistically significant, stricture resolution was less frequent in patients with multiple strictures, longer strictures (>3 cm), and strictures in which scope was not negotiable prior to ATT.
Conclusion
Only one-fourth of ITB patients with strictures show resolution of stricture following ATT. The resolution of strictures is dependent on disease location, and majority of them exhibit symptoms pertaining to stricture even after ATT.
Keywords
Intestinal tuberculosis Anti-tuberculous therapy Stricture Intestinal obstructionNotes
Compliance with ethical standards
Conflict of interest
None to declare.
References
- 1.Kedia S, Sharma R, Nagi B, et al. Computerized tomography-based predictive model for differentiation of Crohn’s disease from intestinal tuberculosis. Indian J Gastroenterol. 2015;34:135–143.CrossRefPubMedGoogle Scholar
- 2.Smith A. Streptomycin in treatment of tuberculosis: Council on Pharmacy and Chemistry. JAMA. 1948;138:548–593.Google Scholar
- 3.Sweany HC, Lichtenstein MR, et al. Streptomycin treatment of tuberculous enterocolitis; results in 30 cases. Am Rev Tuberc. 1949;60:576–588. PubMed PMID: 15392762.PubMedGoogle Scholar
- 4.Mason EF, Kridelbaugh WE. Streptomycin in the treatment of tuberculous enteritis; a report of 33 cases. Am J Med Sci. 1949;217:28–46.CrossRefPubMedGoogle Scholar
- 5.Pimparkar BD. Abdominal tuberculosis. J Assoc Physicians India. 1977;25:801–811.PubMedGoogle Scholar
- 6.Jordan GL Jr, De Bakey ME. Complications of tuberculous enteritis occurring during antimicrobial therapy. AMA Arch Surg. 1954;69:688–693.CrossRefPubMedGoogle Scholar
- 7.Anand BS, Nanda R, Sachdev GK. Response of tuberculous stricture to antituberculous treatment. Gut. 1988;29:62–69.CrossRefPubMedPubMedCentralGoogle Scholar
- 8.Mukewar S, Mukewar S, Ravi R, Prasad A, Dua KS. Colon tuberculosis: endoscopic features and prospective endoscopic follow-up after anti-tuberculosis treatment. Clin Transl Gastroenterol. 2012;3:e24.CrossRefPubMedPubMedCentralGoogle Scholar
- 9.Hara AK, Leighton JA, Heigh RI, et al. Crohn disease of the small bowel: preliminary comparison among CT enterography, capsule endoscopy, small-bowel follow-through, and ileoscopy. Radiology. 2006;238:128–134.CrossRefPubMedGoogle Scholar
- 10.Lee SS, Kim AY, Yang SK, et al. Crohn disease of the small bowel: comparison of CT enterography, MR enterography, and small-bowel follow-through as diagnostic techniques. Radiology. 2009;251:751–761.CrossRefPubMedGoogle Scholar
- 11.Krishna S, Kalra N, Singh P, et al. Small-bowel tuberculosis: a comparative study of MR enterography and small-bowel follow-through. AJR Am J Roentgenol. 2016;207:571–577.CrossRefPubMedGoogle Scholar
- 12.Logan VS. Anorectal tuberculosis. Proc R Soc Med. 1969;62:1227–1230.PubMedPubMedCentralGoogle Scholar
- 13.Paustian F. Tuberculosis of the intestine. In: Bockus HL, ed. Bockus gastroenterology. 5th ed. Philadelphia: Saunders; 1995:3304.Google Scholar
- 14.Pratap Mouli V, Munot K, Ananthakrishnan A, et al. Endoscopic and clinical responses to anti-tubercular therapy can differentiate intestinal tuberculosis from Crohn’s disease. Aliment Pharmacol Ther. 2017;45:27–36.CrossRefPubMedGoogle Scholar
- 15.Nahid P, Dorman SE, Alipanah N, et al. Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: treatment of drug-susceptible tuberculosis. Clin Infect Dis. 2016;63:e147–e195.CrossRefPubMedGoogle Scholar
- 16.Rimola J, Planell N, Rodríguez S, et al. Characterization of inflammation and fibrosis in Crohn’s disease lesions by magnetic resonance imaging. Am J Gastroenterol. 2015;110:432–440.CrossRefPubMedGoogle Scholar
- 17.Booya F, Fletcher JG, Huprich JE, et al. Active Crohn disease: CT findings and interobserver agreement for enteric phase CT enterography. Radiology. 2006;241:787–795.CrossRefPubMedGoogle Scholar
- 18.Bettenworth D, Rieder F. Pathogenesis of intestinal fibrosis in inflammatory bowel disease and perspectives for therapeutic implication. Dig Dis. 2017;35:25–31.CrossRefPubMedGoogle Scholar
- 19.Makharia GK, Ghoshal UC, Ramakrishna BS, et al. Intermittent directly observed therapy for abdominal tuberculosis: a multicenter randomized controlled trial comparing 6 months versus 9 months of therapy. Clin Infect Dis. 2015;61:750–757.CrossRefPubMedGoogle Scholar
- 20.Misra SP, Misra V, Dwivedi M, Arora JS, Kunwar BK. Tuberculous colonic strictures: impact of dilation on diagnosis. Endoscopy. 2004;36:1099–1103.CrossRefPubMedGoogle Scholar